Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Huai'an Anlai Biotechnology Co., Ltd., established on 2018-07-11, Business scope includes biotechnology,medical technology,Genetic Testing Items(Does not include medical activities)research and development,technology transfer,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Prison (Shandong) Biomedical Technology Co., Ltd., established on 2020-07-30, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Jinan Hongfei Biotechnology Co., Ltd., established on 2009-11-10, Business scope includes biotechnology development,to promote;Laboratory equipment and consumables,Sales of Office Supplies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Linjiang Naihua Chinese Medicine Technology Co., Ltd., established on 2015-04-21, Business scope includes research and development of Chinese herbal medicines,to plant,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianke Renxiang Technology (Beijing) Co., Ltd., established on 2006-08-11, Business scope includes technical promotion services.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Hankang Biotechnology (Shenzhen) Co., Ltd., established on 2016-05-27, Business scope includes general business items:electronic cigarette,essential oil,vegetable oil,hemp seed oil,electronic product,Cleaning supplies,Toiletries,Sales of disinfection supplies;Daily Chemicals,cosmetic,Research and development of pet food,Sales;Medical device research and development;Technical development of biological products,technical consulting;Invest in business(Specific projects will be reported separately);Domestic Trade;Operating import and export business.(None of the above items are restricted),The licensing program is:Production of e-liquid,Sales;electronic cigarette,essential oil,vegetable oil,hemp seed oil,electronic product,Cleaning supplies,Toiletries,Production of disinfection products;Daily Chemicals,cosmetic,pet food,bio-pharmacy,Production of Medical Devices;bio-pharmacy,Sales of Medical Devices.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.